Amarin Corp Plc (AMRN)

[jessellivermore]

yellow..

Perhaps you did not notice that my comments do not depend to any degree on the trial design, or even the results. As a matter of fact the trial was open label, blinded endpoint trial..

To me the most remarkable thing about JELIS; the thing that confers the greatest predictive value of JELIS to R-I. is The EPA levels are higher, and the CVD event rates lower, in the composite, active and Placebo arms of the secondary prevention group than in R-I...The facts are the event rates regardless of which arm or the total are so much lower in JELIS than a group of Americans with similar CVD health protocols. And all this with lousy LDL-C levels and low statin doses..

Years of passed since the JELIS results and so far the only the only plausible explanation for these low CVD rates are the high EPA levels in the JELIS population in both active and control arms...This hypothesis is supported by JELIS which confirmed the low EPA levels were associated with high CVD risk regardless of the patient being in the control or active arm...There is no way this result could have been fudged...

":>) JL